The first half of 2005 was marked by several major acquisitions by the companies in the BioCommerce Week Index. Qiagen and Invitrogen were the most aggressive in adding pieces to their businesses. Perhaps the most anticipated acquisition, however, was announced last week with Takara Bio inking an agreement to buy Becton Dickinson's Clontech unit (see article in this week's issue).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.